Horizon Therapeutics Public Ltd Co

LOS ANGELES CAPITAL MANAGEMENT LLC

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/6/2023

Shares

69,368

Value ($000)

8,025

Weight

0.0%

2019 Q4 - 2023 Q3 (12 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/6/2023	8,025	0.0%	69,368	9/30/2023
2023 Q2	8/3/2023	8,567	0.0%	83,296	6/30/2023
2023 Q1	5/4/2023	16,297	0.1%	149,319	3/31/2023
2022 Q4	2/6/2023	16,593	0.1%	145,812	12/31/2022
2022 Q3	11/2/2022	9,600	0.0%	155,116	9/30/2022
2021 Q3	11/8/2021	211	0.0%	1,929	9/30/2021
2021 Q1	5/5/2021	503	0.0%	5,466	3/31/2021
2020 Q4	3/10/2021	6,003	0.0%	82,070	12/31/2020
2020 Q3	11/2/2020	5,341	0.0%	68,751	9/30/2020
2020 Q2	8/5/2020	2,845	0.0%	51,182	6/30/2020
2020 Q1	5/4/2020	555	0.0%	18,728	3/31/2020
2019 Q4	2/7/2020	490	0.0%	13,523	12/31/2019